(Q33596413)

28 July 2017

1 reference

title

The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression? (English)

1 reference

28 July 2017

1 reference

liver transplantation

1 reference

1 reference

1 reference

Papatheodoridis GV

1

1 reference

28 July 2017

Patch D

series ordinal

2

1 reference

28 July 2017

Dusheiko GM

series ordinal

3

1 reference

28 July 2017

Burroughs AK

series ordinal

4

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

published in

Journal of Hepatology

1 reference

28 July 2017

volume

30

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

731-738

1 reference

Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Long-term outcome of hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Hepatitis C viral infection in the immunosuppressed patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Immunopathology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

The quasispecies of hepatitis C virus and the host immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Histological and clinical outcome after liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Quantitation of hepatitis C virus RNA in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

The Effects of Azathioprine and 6 mp on Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

FK506 enhances fibrogenesis in in vitro and in vivo models of liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Treatment for recurrent viral hepatitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Ribavirin therapy for hepatitis C infection following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980208-6

7 January 2021

10.1016/S0168-8278(99)80208-6

Identifiers

DOI

1 reference

release_tlzxizkxmrf6pck2ewcmdzfk74

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tlzxizkxmrf6pck2ewcmdzfk74

24 November 2022

mapped directly with Wikidata item

1 reference